|
AU2016248317A1
|
|
Methods for treating myeloproliferative disorders
|
|
CA2926418A1
|
|
Methods for treating fibrotic cancers
|
|
AU2012358248A1
|
|
Serum amyloid P-antibody fusion proteins
|
|
AU2010262847A1
|
|
SAP variants and their use
|
|
MY158761A
|
|
Serum amyloid p derivatives and their preparation and use
|
|
WO2010115032A1
|
|
Pulmonary and nasal delivery of serum amyloid p
|
|
AU2010224172A1
|
|
Treatment methods for autoimmune disorders
|
|
AU2010224170A1
|
|
Treatment and diagnostic methods for hypersensitive disorders
|
|
AU2008275693A1
|
|
Methods and compositions useful in the treatment of mucositis
|
|
EP2176287A2
|
|
Treatment and diagnostic methods for fibrosis related disorders
|
|
CA2708004A1
|
|
Conjoint therapy for treating fibrotic diseases
|
